BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23209772)

  • 1. MSH3-deficiency initiates EMAST without oncogenic transformation of human colon epithelial cells.
    Campregher C; Schmid G; Ferk F; Knasmüller S; Khare V; Kortüm B; Dammann K; Lang M; Scharl T; Spittler A; Roig AI; Shay JW; Gerner C; Gasche C
    PLoS One; 2012; 7(11):e50541. PubMed ID: 23209772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement.
    Munakata K; Koi M; Kitajima T; Tseng-Rogenski S; Uemura M; Matsuno H; Kawai K; Sekido Y; Mizushima T; Toiyama Y; Yamada T; Mano M; Mita E; Kusunoki M; Mori M; Carethers JM
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00105. PubMed ID: 31789935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.
    Haugen AC; Goel A; Yamada K; Marra G; Nguyen TP; Nagasaka T; Kanazawa S; Koike J; Kikuchi Y; Zhong X; Arita M; Shibuya K; Oshimura M; Hemmi H; Boland CR; Koi M
    Cancer Res; 2008 Oct; 68(20):8465-72. PubMed ID: 18922920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetranucleotide Microsatellite Mutational Behavior Assessed in Real Time: Implications for Future Microsatellite Panels.
    Raeker MÖ; Pierre-Charles J; Carethers JM
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):689-704. PubMed ID: 31982570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMAST status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for Stage II/III colorectal cancer.
    Mohammadpour S; Goodarzi HR; Jafarinia M; Porhoseingholi MA; Nazemalhosseini-Mojarad E
    J Cell Physiol; 2020 Apr; 235(4):3604-3611. PubMed ID: 31549400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress induces nuclear-to-cytosol shift of hMSH3, a potential mechanism for EMAST in colorectal cancer cells.
    Tseng-Rogenski SS; Chung H; Wilk MB; Zhang S; Iwaizumi M; Carethers JM
    PLoS One; 2012; 7(11):e50616. PubMed ID: 23226332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between MSH3 immunohistochemistry and microsatellite analysis for the detection of elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in colorectal cancers.
    Laycock A; Kang A; Ang S; Texler M; Bentel J
    Hum Pathol; 2021 Dec; 118():9-17. PubMed ID: 34537247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias.
    Lee SY; Chung H; Devaraj B; Iwaizumi M; Han HS; Hwang DY; Seong MK; Jung BH; Carethers JM
    Gastroenterology; 2010 Nov; 139(5):1519-25. PubMed ID: 20708618
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Villy MC; Masliah-Planchon J; Schnitzler A; Delhomelle H; Buecher B; Filser M; Merchadou K; Golmard L; Melaabi S; Vacher S; Blanluet M; Suybeng V; Corsini C; Dhooge M; Hamzaoui N; Farelly S; Ait Omar A; Benamouzig R; Caumette V; Bahuau M; Cucherousset J; Allory Y; Stoppa-Lyonnet D; Bieche I; Colas C
    J Med Genet; 2023 Nov; 60(12):1198-1205. PubMed ID: 37402566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer.
    Rashid M; Rashid R; Gadewal N; Carethers JM; Koi M; Brim H; Ashktorab H
    Neoplasia; 2024 Mar; 49():100970. PubMed ID: 38281411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability.
    Plaschke J; Preußler M; Ziegler A; Schackert HK
    Int J Colorectal Dis; 2012 Jul; 27(7):911-9. PubMed ID: 22249440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMAST Type of Microsatellite Instability-A Distinct Entity or Blurred Overlap between Stable and MSI Tumors.
    Vuković Đerfi K; Salar A; Cacev T; Kapitanović S
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma.
    Mori T; Hamaya Y; Uotani T; Yamade M; Iwaizumi M; Furuta T; Miyajima H; Osawa S; Sugimoto K
    PLoS One; 2018; 13(12):e0208557. PubMed ID: 30532127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progression.
    Plaschke J; Krüger S; Jeske B; Theissig F; Kreuz FR; Pistorius S; Saeger HD; Iaccarino I; Marra G; Schackert HK
    Cancer Res; 2004 Feb; 64(3):864-70. PubMed ID: 14871813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.
    Lee HS; Park KU; Kim DW; Lhn MH; Kim WH; Seo AN; Chang HE; Nam SK; Lee SY; Oh HK; Kang SB
    Curr Mol Med; 2016; 16(9):829-839. PubMed ID: 27889996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method for discovering EMAST sequences in animal models of cancer.
    Bhaskaran N; Luu J; Kelley ST; Khan MW; Mamindla P; McGuire KL
    Sci Rep; 2018 Sep; 8(1):13764. PubMed ID: 30214002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells.
    Tseng-Rogenski SS; Hamaya Y; Choi DY; Carethers JM
    Gastroenterology; 2015 Mar; 148(3):579-89. PubMed ID: 25461668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells.
    Park JM; Huang S; Tougeron D; Sinicrope FA
    PLoS One; 2013; 8(5):e65369. PubMed ID: 23724141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression.
    Carethers JM; Koi M; Tseng-Rogenski SS
    Genes (Basel); 2015 Mar; 6(2):185-205. PubMed ID: 25836926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.